VFPI
BMY icon

Vantage Financial Partners (Illinois)’s Bristol-Myers Squibb BMY Stock Holding History

Vantage Financial Partners (Illinois)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,425
Closed -$565K – 106
2024
Q1 		$565K Buy
10,425
+150
+1% +$7.64K 0.15% 67
2023
Q4 		$527K Sell
10,275
-2,400
-19% -$126K 0.16% 69
2023
Q3 		$736K Sell
12,675
-725
-5% -$44.4K 0.42% 42
2023
Q2 		$857K Sell
13,400
-200
-1% -$13.4K 0.48% 40
2023
Q1 		$943K Sell
13,600
-1,175
-8% -$82.9K 0.56% 39
2022
Q4 		$1.06M Sell
14,775
-300
-2% -$22.6K 0.61% 41
2022
Q3 		$1.07M Sell
15,075
-1,725
-10% -$125K 0.69% 30
2022
Q2 		$1.29M Hold
16,800
– – 0.77% 26
2022
Q1 		$1.23M Sell
16,800
-400
-2% -$26.9K 0.64% 34
2021
Q4 		$1.07M Buy
17,200
+600
+4% +$35.2K 0.54% 36
2021
Q3 		$982K Sell
16,600
-1,800
-10% -$119K 0.52% 37
2021
Q2 		$1.23M Buy
18,400
+500
+3% +$32.6K 0.68% 29
2021
Q1 		$1.13M Hold
17,900
– – 0.64% 31
2020
Q4 		$1.11M Buy
17,900
+900
+5% +$55.3K 0.64% 31
2020
Q3 		$1.02M Buy
17,000
+500
+3% +$30.1K 0.63% 32
2020
Q2 		$970K Buy
16,500
+400
+2% +$23.9K 0.61% 28
2020
Q1 		$897K Buy
16,100
+3,500
+28% +$214K 0.65% 28
2019
Q4 		$809K Buy
12,600
+3,100
+33% +$178K 0.47% 33
2019
Q3 		$482K Buy
9,500
+3,400
+56% +$160K 0.32% 40
2019
Q2 		$277K Buy
6,100
+400
+7% +$18.6K 0.18% 71
2019
Q1 		$272K Sell
5,700
-900
-14% -$44.8K 0.18% 63
2018
Q4 		$343K Buy
6,600
+500
+8% +$26.9K 0.25% 51
2018
Q3 		$379K Hold
6,100
– – 0.24% 54
2018
Q2 		$338K Hold
6,100
– – 0.22% 60
2018
Q1 		$386K Buy
6,100
+300
+5% +$19.3K 0.26% 54
2017
Q4 		$358K Buy
5,800
+100
+2% +$6.25K 0.24% 56
2017
Q3 		$362K Buy
+5,700
New +$333K 0.25% 49

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vantage Financial Partners (Illinois)'s BMY Position: Q2 2024 in Review

Vantage Financial Partners (Illinois) sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 10,425 shares — an estimated $565K sold.

Vantage Financial Partners (Illinois) first reported a position in BMY in Q3 2017 and held it in 27 quarters. The position peaked at $1.29M in Q2 2022. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Vantage Financial Partners (Illinois) reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Vantage Financial Partners (Illinois) sold 10,425 Bristol-Myers Squibb shares in Q2 2024, an estimated $565K.
  • Vantage Financial Partners (Illinois) first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 27 quarters.
  • Vantage Financial Partners (Illinois)'s Bristol-Myers Squibb position peaked at $1.29M in Q2 2022.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q2 2024, filed 14 Aug 2024.